Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Scientific Officer
-
Stock Symbol
-
JANX on Nasdaq
There are no Buy or Sell transactions made by Shahram Salek-Ardakani since 12/22/2023
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Stock Option (right to buy) |
114K |
|
|
Jan 3, 2022 |
Direct |
Common Stock |
|
Transactions reported by Shahram Salek-Ardakani for Janux Therapeutics, Inc.
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.